greeksoup/ stock research

Church & Dwight Co. Inc.: Q4 FY2025 earnings call

What management said about Q4 FY2025, from the documents filed with the SEC on 30 January 2026: press release. Guidance figures: 2 raised, 18 new. The quarter’s numbers.

Key takeaways

  • Q4 net sales above prior expectation: Q4 net sales were $1,644.2 million, up 3.9% year over year, above the company's prior expectation of 3.5% growth. Source
  • Q4 organic growth below expectation: Organic sales rose 0.7% in Q4 against about 1.5% expected. Management cited weaker category growth and lower vitamin sales. Excluding the exited VMS business, organic growth was 1.8%. Source
  • Full-year adjusted EPS $3.53: Full-year reported EPS was $3.02, up 27.4% against a prior year that included a $270.1 million non-cash vitamin charge. Adjusted EPS was $3.53, up 2.6%. Source
  • Launches to drive half of growth: Management expects 2026 new product launches to drive about half of organic growth, across a number of key categories. Source
  • Three growth initiatives announced: Management announced three incremental initiatives: ARM & HAMMER brand expansion, oral care growth behind THERABREATH, and international expansion with an acquisition focus. Source

“In a mixed consumer and macroeconomic environment, we are pleased to deliver another year of industry-leading results”

Rick Dierker, Chief Executive Officer

Guidance

AreaPeriodFigureAgainst last quarter
Organic sales growth SourceFY2026approximately 3% to 4%New
Reported net sales SourceFY2026decline of approximately 1.5% to 0.5%New
Adjusted gross margin SourceFY2026expand approximately 100 basis points from 2025New
Marketing expense as % of sales SourceFY2026exceed 11%New
SG&A as % of sales SourceFY2026higher than 2025New
Adjusted other expense SourceFY2026approximately $75.0 millionNew
Adjusted tax rate SourceFY2026approximately 21.5%New
Reported EPS growth SourceFY2026increase approximately 18% to 22%New
Reported diluted EPS SourceFY2026$3.57 to $3.67New
Adjusted EPS growth SourceFY20265% to 8%New
Adjusted diluted EPS SourceFY2026$3.71 to $3.81New
ERP project impact excluded from adjusted EPS SourceFirst half of FY20261% impactNew
Cash flow from operations SourceFY2026approximately $1.15 billionNew
Capital expenditures SourceFY2026approximately $130 millionNew
Organic sales growth SourceQ1 2026approximately 3%New
Reported net sales SourceQ1 2026decline of approximately 1%New
Adjusted diluted EPS SourceQ1 2026$0.92 per shareNew
Tax rate SourceQ1 2026approximately 21%New
Quarterly dividend per share SourceDeclared for Q1 2026 payment$0.3075Raised from $0.295
Annual dividend payout SourceFY2026approximately $291 millionRaised from $287 million in 2025

What changed from last quarter

  • New guidance: 2026 organic sales growth guidance of 3% to 4% was issued; the prior release gave 2025 guidance only. Source
  • New guidance: 2026 adjusted EPS growth guidance of 5% to 8% was issued, with growth expected mainly in the second half. Source
  • New guidance: First-quarter 2026 adjusted EPS guidance of $0.92 per share was issued. Source
  • New: Three incremental growth initiatives for 2026 to 2030 were announced: ARM & HAMMER expansion, oral care growth behind THERABREATH, and international expansion with an acquisition focus. Source
  • Ended: The VITAFUSION and L’IL CRITTERS vitamin business was sold to Piping Rock, closing December 31, 2025. The prior release said the review would conclude by end of 2025. Source
  • Ended: Exits of the FLAWLESS, SPINBRUSH and WATERPIK showerhead businesses are described as completed in 2025; the prior release had them due by early 2026. Source
  • New: Organic sales reporting will exclude the VMS business from prior periods starting in 2026. Source

Fourth-quarter and full-year results

  • Q4 net sales above prior expectation: Q4 net sales were $1,644.2 million, up 3.9% year over year, above the company's prior expectation of 3.5% growth. Source
  • Q4 organic growth below expectation: Organic sales rose 0.7% in Q4 against about 1.5% expected. Management cited weaker category growth and lower vitamin sales. Excluding the exited VMS business, organic growth was 1.8%. Source
  • Q4 reported EPS hit by VMS charge: Q4 reported EPS was $0.60, down 21.1%, including an after-tax VMS exit charge of $45.6 million. Adjusted EPS was $0.86, up 11.7%, after added marketing investment. Source
  • Full-year sales growth 1.6%: Full-year net sales were $6,203.2 million, up 1.6%, above the 1.5% prior expectation. Organic growth was 0.7%, with a 130 basis point effect from the exited VMS business. Source
  • Full-year adjusted EPS $3.53: Full-year reported EPS was $3.02, up 27.4% against a prior year that included a $270.1 million non-cash vitamin charge. Adjusted EPS was $3.53, up 2.6%. Source

Segments and regions

  • Consumer Domestic organic sales flat: Consumer Domestic sales were $1,271.2 million, up 3.7%. Organic sales fell 0.1%, or rose 1.7% excluding exited VMS. Price and mix added 0.6%, offset by 0.7% lower volume. Source
  • Consumer International led growth: International sales were $299.8 million, up 5.2%. Organic growth of 3.6% came from 2.9% higher volume and 0.7% price and mix, led by HERO, THERABREATH and baking soda. Source
  • Specialty Products up 2.8%: Specialty Products sales were $73.2 million, up 2.8%, all organic. Volume added 2.2% and price and mix 0.6%. Gross margin rose 110 basis points to 45.8%. Source
  • Domestic full-year share gains: The domestic division's organic sales fell 0.5% for the full year, while it gained market share in four of its eight power brands. International organic growth was 5.5%. Source
  • Second-half organic growth strengthened: Organic growth in all three divisions strengthened from the first half to the second half of 2025, with overall organic sales growing 2% in the second half. Source

“We are confident these actions will enable the Company to achieve future evergreen business growth even if category growth remains sluggish as a result of external factors and even stronger growth if categories normalize.”

Church & Dwight Co. Inc., press release

Products and innovation

  • Launches to drive half of growth: Management expects 2026 new product launches to drive about half of organic growth, across a number of key categories. Source
  • TOUCHLAND drove reported growth: Consumer Domestic reported sales growth was fueled by TOUCHLAND, which grew at a double-digit rate versus the prior year. Source
  • TROJAN G.O.A.T. ahead of prior launch: Since its Q4 2025 launch, TROJAN G.O.A.T. condoms are outperforming the prior TROJAN RAW launch. They are the #1 rated TROJAN condom on Amazon, with a 4.7-star rating. Source
  • THERABREATH toothpaste reviews: THERABREATH toothpaste launched online in August in three variants. Initial consumer reviews across platforms average 4.6, and the product is arriving in stores now. Source
  • ARM & HAMMER value laundry expansion: A Baking Soda Fresh laundry detergent with 10x more baking soda expands the value tier of the laundry portfolio. ARM & HAMMER Cat Litter with DUAL DEFENSE also launched. Source

Margins, marketing and costs

  • Q4 adjusted gross margin up 90 bps: Q4 adjusted gross margin was 45.5%, up 90 basis points and 140 basis points above the company's expectation. Productivity, volume and mix offset inflation and tariffs. Source
  • Full-year adjusted margin held flat: Full-year adjusted gross margin held at 45.2%, as productivity, volume and mix offset inflation and tariffs after mitigation. Reported gross margin fell 100 basis points. Source
  • Q4 marketing spend rose: Q4 marketing expense was $212.3 million, up $4.4 million, as the company keeps investing in brands and new products for share gains and household penetration. Source
  • SG&A carried TOUCHLAND charges: Q4 SG&A was $275.5 million, including $18.3 million of restricted stock and earnout charges from TOUCHLAND. Adjusted SG&A was 15.4% of sales, up 20 basis points. Source
  • Q4 tax rate lower year over year: The Q4 adjusted effective tax rate was 21.7%, against 24.9% a year earlier, with lower state taxes. Adjusted other expense rose $15.6 million on lower interest income. Source

“The strength of our brands, portfolio re-shaping, and the new growth initiatives give us renewed confidence as we enter 2026”

Rick Dierker, Chief Executive Officer

Demand, consumption and category growth

  • Categories slowed during 2025: Management said some categories decelerated in 2025 amid global macro uncertainty, and weaker category growth limited Q4 organic sales. Source
  • US consumption excluding exits 3.5%: US consumption grew 0.9% on a reported basis in 2025. Excluding the exited businesses, consumption growth was 3.5%, according to management. Source
  • Share gains in slowing categories: Management said the company gained share in slowing categories during 2025, driven by focused innovation, marketing and promotional spending. Source

Portfolio exits and vitamin sale

  • VITAFUSION sold to Piping Rock: The VITAFUSION and L'IL CRITTERS brands, related trademarks and two Washington facilities were sold to Piping Rock, closing December 31, 2025. VMS was under 5% of 2025 sales. Source
  • One-time VMS exit charge: The transaction produced a one-time after-tax charge of $45.6 million in Q4 2025. The VMS brands represented less than 5% of 2025 net sales. Source
  • Other exits completed in 2025: FLAWLESS, SPINBRUSH and the WATERPIK showerhead line were exited in 2025. The prior release had those exits due by early 2026. Source
  • 2025 exits reduce 2026 revenue: Management said the 2025 business exits represented $400 million of lower revenue and related stranded costs, which 2026 guidance absorbs. Source
  • VMS dropped from organic reporting: Starting in 2026, organic sales reporting will exclude the VMS business from prior periods. Source

Cash flow, capital and shareholder returns

  • Full-year cash from operations $1.2 billion: Full-year cash from operations was $1.2 billion, up $59.2 million, driven by higher cash earnings and working capital improvement actions. Source
  • Capex fell to normalized levels: Full-year capital expenditures were $122.4 million, $57.4 million lower, mainly from a return to normalized capital spending levels in 2025. Source
  • Debt and cash at year end: At December 31, 2025, total debt was $2.2 billion and cash on hand was $409.0 million. Management said this supports pursuing acquisitions. Source
  • Q4 buybacks $300 million: The company repurchased an additional $300 million of shares in Q4, bringing 2025 repurchases to $900 million. Source
  • Quarterly dividend up 4.2%: The quarterly dividend rises 4.2%, to $0.3075 per share, the 30th consecutive annual increase. Total payout rises to about $291 million a year. Source

Growth initiatives for 2026 to 2030

  • Three growth initiatives announced: Management announced three incremental initiatives: ARM & HAMMER brand expansion, oral care growth behind THERABREATH, and international expansion with an acquisition focus. Source
  • Historical growth framework: Categories grew at a weighted average of 3% for many years. With share gains, that enabled the company to grow organic sales at about 4%, which 2025 category slowdowns affected. Source
  • Acquisitions across the globe: The company will keep pursuing acquisitions worldwide that meet strict criteria, with emphasis on fast-moving consumable products like THERABREATH, HERO and TOUCHLAND. Source

Coming up, as management said on 30 January 2026

  • 2026 Analyst Day details: Management said it would discuss each growth initiative in more detail at the 2026 Analyst Day later that day. Source
  • Dividend payable March 2, 2026: The quarterly dividend is payable March 2, 2026, to stockholders of record at the close of business on February 13, 2026. Source
  • Second-half weighted EPS growth: Management expects 2026 EPS growth mainly in the second half, as first-half marketing investment and TOUCHLAND amortization and SG&A weigh on results. Source
  • HERO cleansers launch mid-2026: A three-SKU line of HERO facial cleansers will launch nationally in mid-year 2026. Source

Figures management reported

FigureReported
Consumer Domestic volume growth, Q4 Source-0.7%
Consumer International volume growth, Q4 Source+2.9%
Specialty Products volume growth, Q4 Source+2.2%
US consumption growth excluding exited businesses, 2025 Source3.5%

Risks management discussed

  • Demand: Management said some categories slowed in 2025 under global macro uncertainty, which limited organic growth. Source
  • Operational: An ERP upgrade project runs through the first half of 2026, with expenses excluded from adjusted EPS. Source
  • Financial: Adjusted other expense rises to about $75.0 million in 2026 because interest income is lower. Source
  • Regulatory: Tariff costs and higher inflation are expected to be offset by volume, productivity and mix in 2026. Source

Earlier plans management reported on

  • Ahead: Q4 adjusted gross margin of 45.5% was 140 basis points above management's expectation. Source
  • Not stated: The exits, previously due by early 2026, are described in this release as taken in 2025. The release does not give a status label. Source

Other quarters

Summarised with AI from the documents the company filed with the SEC. Every point is checked against the filing before it is shown: management’s own words word for word, figures against the line or table row they come from. A point that fails the check is left out. Source opens the filing at that line.